Building a Self-Reliant India: PYG Lifesciences’ Vision for a Future Beyond Imports
INTRODUCTION
India is recognized globally as the “Pharma Capital of the World.” However, despite our leadership in pharmaceuticals, India continues to import around 90% of its pharmaceutical intermediates and raw materials, primarily from countries like China. This heavy reliance came into sharp focus during the COVID-19 pandemic, highlighting the urgent need for self-reliance.
At PYG Lifesciences, we are committed to transforming this challenge into an opportunity. Our mission is to support the vision of Atmanirbhar Bharat—India’s journey toward self-reliance.
At PYG Lifesciences, we are committed to transforming this challenge into an opportunity. Our mission is to support the vision of Atmanirbhar Bharat—India’s journey toward self-reliance.
1. THE IMPORT CHALLENGE: A DEPENDENCE ON FOREIGN SUPPLIERS
Despite being a major player in the global pharmaceutical industry, India’s dependence on foreign imports for raw materials and intermediates is significant. The COVID-19 pandemic was a wake-up call, underlining the risks associated with this reliance.
⚠️ The lesson was clear: India needs to secure its own supply chains to safeguard its industries.
⚠️ The lesson was clear: India needs to secure its own supply chains to safeguard its industries.
2. OUR ROLE TOWARDS MANUFACTURING FOR SELF-RELIANCE
At PYG Lifesciences, our response to this challenge is to manufacture pharmaceutical API intermediates and specialty chemicals domestically. We are not just filling a gap but actively contributing to reducing India’s dependency on imports by focusing on high-quality production that can power industries ranging from pharmaceuticals to daily necessities.
3. THE ROLE OF GOVERNMENT SUPPORT
Innovation in pharmaceutical manufacturing would not be possible without facilities.
Speciality manufacturers invest in the latest technologies to meet the regulatory and quality standards of the industry.
From automated production lines to advanced quality control systems, these facilities ensure that the drugs produced are safe, effective, and meet international compliance requirements.
This investment in technology helps manufacturers maintain high standards and enables them to adopt sustainable and eco-friendly manufacturing practices.
From automated production lines to advanced quality control systems, these facilities ensure that the drugs produced are safe, effective, and meet international compliance requirements.
This investment in technology helps manufacturers maintain high standards and enables them to adopt sustainable and eco-friendly manufacturing practices.
4. ALIGNING WITH “MAKE IN INDIA, MAKE FOR THE WORLD”
We strongly believe in Prime Minister Shri Narendra Modi Ji’s vision of “Make in India, Make for the World.” Our focus is not only on local sourcing and manufacturing but also on developing local talent. By fostering innovation and skill development, we are ensuring that India’s pharmaceutical sector continues to thrive on both the domestic and global stage.
5. LONG-TERM VISION: INNOVATION AND GLOBAL LEADERSHIP
We are dedicated to building a future where India becomes a global hub for innovation and manufacturing. By focusing on local production, talent development, and self-reliance, PYG Lifesciences is committed to supporting India’s growth into a leading manufacturer in the pharmaceutical industry.
CONCLUSION
At PYG Lifesciences, we view India’s dependence on imported raw materials as an opportunity to promote self-reliance. By aligning ourselves with the Government of India’s vision, we are proud to be part of a movement that aims to secure India’s future as a global leader in pharmaceutical innovation and manufacturing. Together, we can build a stronger, self-reliant India.
